400 participants
IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-09-01
- Start Date:
- 2023-08-09
- Completion:
- 2027-09-30
Conditions
- Refractory Cancer
- Recurrent Cancer
- Solid Tumor, Adult
- Cancer
Interventions
- DRUG
No Results Yet